InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Runge Jeffrey W., Director. Insider active across 1 company, notably Aditx Therapeutics, Inc.. In total, 2 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €3k. Activity tracked since 1 June 2021. The latest transaction was disclosed on 1 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Jeffrey W. Runge is a Board Member at Aditx Therapeutics, Inc. In this role, he actively participates in board discussions and contributes to strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to board discussions. He is committed to promoting best governance practices and ensuring the company's sustainability.